14 November 2022 | Geneva: Today marks World Diabetes Day and this year’s theme is “access to diabetes education”, which underpins the larger multi-year theme of “access to care”. The theme highlights the importance of empowering individuals and communities with the right information to help improve the lives of close to half a billion people living with diabetes worldwide. People with diabetes have a higher risk of developing tuberculosis (TB), and of poor TB treatment outcomes.  Access to education on diabetes will therefore help increase awareness and improve the quality of life for people and families affected by diabetes and TB.

Vulnerable populations in 45 high-burden countries worldwide must be prioritised in efforts to reduce the impact of the COVID-19 pandemic on tuberculosis (TB) care, according to new research published in BMC Medicine.

-- GSK3036656 demonstrated early bactericidal activity with a low, once-daily oral dose after 14 days of treatment in participants with drug-susceptible pulmonary tuberculosis
-- Treatment was generally well tolerated with no serious adverse events identified
-- Results demonstrate the potential for this asset to be a component of simpler TB treatment regimens in the future
-- TB remains leading global cause of death from infectious disease and new treatments are urgently needed

Materials designed to equip civil society and community-based organizations with the information they need to advocate for equitable access to the short-course treatment and prevention regimens at the heart of the 1/4/6×24 Campaign.

Treatment Action Group launches the 2022 Tuberculosis Diagnostics Pipeline Report.

For the third year in a row, the 2022 Union World Conference on Lung Health was held virtually due to the COVID-19 pandemic on 8-11 November 2022 under the theme Combating Pandemics: Today & Tomorrow.

Joint position statement and global solidarity appeal from TB communities to all TB stakeholders

Two treatment regimens for multidrug-resistant TB, containing the first new drug to have been discovered for the disease in 40 years, are more effective than a previously recommended treatment, according to results from a global trial led by UCL researchers.

Dr Madhukar Pai, Professor & Canada Research Chair at McGill University, Montreal, gave this thought-provoking speech during the opening ceremony of The Union World Conference on Lung Health 2022.

Тhe World Health Organization and the Stop TB Partnership with support from the U.S. Agency for International Development and the Global Fund to Fight AIDS, Tuberculosis and Malaria convened a meeting of the Global Working Group on Public-Private Mix for TB Care and Prevention in Nairobi, Kenya on 2-4 November 2022.